What Synecor does

Synecor is a privately held, for-profit entity headquartered in Chapel Hill, North Carolina, founded in 2000. The firm describes itself as having emerged from several synergistic strategic relationships originally centered on interventional cardiology. Beyond this stated origin, no detailed functional description, product portfolio, or service offerings are disclosed in the available data; the company's website (synecor.com) is not accessible and resolves only to a verification/loading page. Leadership is anchored by CEO and co-founder William Starling, with no additional management team information available in the provided sources.

The firm operates with a very small team (1-10 employees), and the available record shows two financing events — one from Asset Management Ventures (AMV) in May 2013 and one from Synergy Life Science Partner in January 2020 — both with undisclosed funding amounts. There are no recorded products, customers, pricing models, partnerships, acquisitions, or revenue data in the input. The combination of a multi-decade operating history, life sciences investor participation, original interventional cardiology focus, and extremely small headcount suggests Synecor may function as a strategic vehicle for incubation, spin-out formation, or specialized venture activity in the medical device space rather than as a scaled operating company, though this characterization cannot be confirmed from the available evidence.

No go-to-market motion, revenue mechanics, customer segments, or distribution channels have been disclosed. The absence of marketing channels, app, API, or integration footprint indicates limited observable commercial activity. Overall, the data describes a long-standing but extremely lean private entity with cardiac medical roots and a sparse public footprint.

Name

Synecor

Website

https://synecor.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Synecor is a privately held, Chapel Hill-based entity founded in 2000 that originated from strategic relationships in interventional cardiology, operating with a 1-10 person team under co-founder and CEO William Starling.

Ownership category

akta.pro rank

Product category

Interventional Cardiology Medical Devices

NAICS

Scientific Research and Development Services (5417)

akta.pro primary industry

Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)

Keywords

• Interventional cardiology
• Medical devices
• Cardiovascular implants
• Cardiac therapy devices
• Minimally invasive cardiology

Headquarters

HQ city

Chapel Hill

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Others

Core offering

Synecor is a medical device company operating in the field of interventional cardiology, formed from the convergence of synergistic strategic relationships. The company develops and advances cardiovascular therapy products, including implants and minimally invasive devices, targeting structural heart and related interventional cardiology applications. Its activities center on bringing next-generation interventional cardiology technologies to clinical use.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights1 record

Direct peers

• The Foundry: The Foundry is a medical device incubator based in the San Francisco Bay Area that creates, funds, and operates early-stage device companies — the closest direct analogue to Synecor's venture-creation model, including cardiovascular programs.
• InCube Labs: InCube Labs is a life-sciences incubator founded by Mir Imran that builds and spins out medical device and therapeutic companies, sharing Synecor's founder-led incubator approach and cardiovascular device exposure.
• ExploraMed: ExploraMed is a medical device incubator founded by Dr. Josh Makower that has created multiple device ventures, including in interventional and minimally invasive therapy — directly comparable in business model to Synecor.
• TauTona Group: TauTona Group is a medical device accelerator that incubates early-stage device companies with a hands-on operational model similar to Synecor's, focused on rapidly advancing concepts toward clinical and commercial milestones.
• Fogarty Institute for Innovation: The Fogarty Institute is a nonprofit medical device incubator that mentors and funds early-stage device entrepreneurs, sharing Synecor's model of nurturing small device teams from concept through clinical development.

Broad incumbents

• Edwards Lifesciences: Edwards Lifesciences is a global leader in interventional cardiology and structural heart devices, representing the broad incumbent endpoint for cardiovascular device innovation that Synecor's portfolio companies could feed into or partner with.
• Medtronic: Medtronic is one of the largest interventional cardiology and cardiac device incumbents globally, serving as a strategic acquirer and channel for early-stage cardiovascular technologies incubated by firms like Synecor.
• Abbott Laboratories: Abbott operates one of the broadest cardiovascular and interventional cardiology portfolios and is a frequent acquirer of early-stage device assets, making it a comparable incumbent endpoint for Synecor-style incubators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synecor